238 Results for "

repeat

" in MedChemExpress (MCE) Product Catalog:
Products (238)

238 Results for "repeat" in MCE Product Catalog:

33
33 Publications Verification
Cat. No.: HY-P0319
CAS No.: 402750-12-3
Research Areas:  

Others

3X FLAG peptides are FLAG-tagged peptides containing three repeats of the Asp-Tyr-Lys-Xaa-Xaa-Asp motif. 3X FLAG peptide can be used for protein separation and purification, and competitive elution with target proteins.
loading...
    loading...
33
33 Publications Verification
Cat. No.: HY-P0319A
Target:  

Peptides

Research Areas:  

Others

3X FLAG peptide TFA is a FLAG-tagged peptide containing three repeats of the Asp-Tyr-Lys-Xaa-Xaa-Asp motif. 3X FLAG peptide TFA can be used for protein separation and purification, and competitive elution with target proteins.
loading...
    loading...
15
15 Cited Publications
Cat. No.: HY-16993
CAS No.: 1801787-56-3
Target:  

Apoptosis WDR5

Research Areas:  

Cancer

OICR-9429, a chemical probe, is high affinity WD repeat domain 5 (WDR5) inhibitor, competitively blocks WDR5 interaction with MLL protein via binding the central peptide-binding pocket of WDR5. OICR-9429 can suppress histone H3K4 trimethylation and can be used for the research of various cancers including non-MLL-rearranged leukaemia, colon, pancreatic, prostate cancer and bladder cancer (BCa) .
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-P70664
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Fibronectin type III domain-containing protein 5; Fibronectin type III repeat-containing protein 2; Irisin; FNDC5
Species:  
Source:  
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-111753
CAS No.: 2407457-36-5
Purity:  98.13%
Target:  

WDR5 Apoptosis

Research Areas:  

Cancer

WDR5-IN-4 (Compound C6) is a WIN site inhibitor of chromatin-associated WD repeat domain 5 protein (WDR5), Kd The value is 0.1 nM. WDR5-IN-4 is able to displace WDR5 from chromatin and reduce the expression of related genes, causing translation inhibition and nucleolar stress. Has anti-cancer effects .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-111753A
CAS No.: 2749300-35-2
Purity:  99.87%
Target:  

WDR5 Apoptosis

Research Areas:  

Cancer

WDR5-IN-4 TFA (Compound C6) is an inhibitor of the WIN site of chromatin-associated WD repeat-containing protein 5 (WDR5), with a Kd of 0.1 nM. WDR5-IN-4 TFA displaces WDR5 from chromatin and decreases the expression of associated genes, causing translational inhibition, nucleolar stress. Anti-cancer activity .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-P70092
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: rHuCollagen triple helix repeat-containing protein 1/CTHRC1, His; Collagen triple helix repeat-containing protein 1; Protein NMTC1; CTHRC1
Species:  
Source:  
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-120085
CAS No.: 1527475-61-1
Purity:  99.48%
Synonyms: PF-06685360
Target:  

LRRK2

Research Areas:  

Neurological Disease

PFE-360 (PF-06685360) is a potent, selective, brain penetrated and orally active leucine-rich repeat kinase 2 (LRRK2) inhibitor with a mean IC50 of 2.3 nM in vivo .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-P70665
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Fibronectin type III domain-containing protein 5; Fibronectin type III repeat-containing protein 2; Irisin; FNDC5
Species:  
Source:  
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-19347
CAS No.: 890190-22-4
Synonyms: WD-repeat Protein 5-0103
Target:  

WDR5

Research Areas:  

Neurological Disease Cancer

WDR5-0103 (WD-Repeat Protein 5-0103) is a potent and selective WD repeat-containing protein 5 (WDR5) antagonist with a Kd of 450 nM. WDR5-0103 competitively binds to the peptide-binding pocket of WDR5, blocking the interaction between WDR5 and mixed-lineage leukemia (MLL) protein and inhibiting the methyltransferase activity of MLL. WDR5-0103 is mainly used in the research of cancer and neurodegenerative diseases .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-15839
CAS No.: 1314241-44-5
Purity:  99.74%
Research Areas:  

Cancer

UNC 669, a ligand for a methyl-lysine binding domain, is a potent L3MBTL1 (IC50=4.2 uM) and L3MBTL3 (3.1 uM) inhibitor .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-129087
CAS No.: 1507370-40-2
Purity:  99.26%
Target:  

Apoptosis

Research Areas:  

Cancer

BC-1258,an F-box/LRR-repeat protein 2 (FBXL2) activator,can stabilize and upregulate FBXL2 levels. BC-1258 induces apoptosis of tumorigenic cells,and profoundly inhibits tumor formation in mice .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P79308
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: Leucine-rich repeat-containing G-protein coupled receptor 5; LGR5; G-protein coupled receptor 49; G-protein coupled receptor 67; G-protein coupled receptor HG38; GPR49; GPR67; Leucine-rich repeat Containing G Protein-coupled Receptor 5
Species:  
Source:  
CHO
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P701373
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: CDK8; CCNC; MED12; Cyclin-dependent kinase 8; Cell division protein kinase 8; Mediator complex subunit CDK8; Mediator of RNA polymerase II transcription subunit CDK8; Protein kinase K35; Cyclin-C; SRB11 homolog; hSRB11; Mediator of RNA polymerase II transcription subunit 12; Activator-recruited cofactor 240 kDa component; ARC240; CAG repeat protein 45; Mediator complex subunit 12; OPA-containing protein; Thyroid hormone receptor-associated protein complex 230 kDa component; Trap230; Trinucleotide repeat-containing gene 11 protein
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-141796
CAS No.: 2407452-77-9
Purity:  98.64%
Target:  

PROTACs WDR5

Research Areas:  

Cancer

MS67 is a potent and selective WD40 repeat domain protein 5 (WDR5) degrader with a Kd of 63 nM. MS67 is inactive against other protein methyltransferases, kinases, GPCRs, ion channels, and transporters. MS67 shows potent acticancer effects .
loading...
    loading...
Cat. No.: HY-141799
CAS No.: 2407458-49-3
Purity:  98.05%
Research Areas:  

Cancer

Dimethyl-F-OICR-9429-COOH a ligand for WD40 repeat domain protein 5 (WDR5) extracted from patent WO2019246570A1 intermediate 19. Dimethyl-F-OICR-9429-COOH can be used in the synthesis of PROTACs .
loading...
    loading...
Cat. No.: HY-P4808
CAS No.: 329897-62-3
Target:  

Amyloid-β Autophagy

Research Areas:  

Neurological Disease

PHF6 (VQIVYK) is a self-assembly sequence capable of initiating the full-length tau protein aggregation and is mapped to the third microtubule-binding repeat region of the tau protein .
loading...
    loading...
Cat. No.: HY-12282
CAS No.: 1536200-31-3
Purity:  99.72%
Target:  

LRRK2

Research Areas:  

Neurological Disease

GNE-9605 is a potent, orally active, selective Leucine-rich repeat kinase 2 (LRRK2) inhibitor with an IC50 value of 18.7 nM. GNE-9605 inhibits LRRK2 Ser1292 autophosphorylation. GNE-9605 can be used in research of Parkinson's disease (PD) .
loading...
    loading...
Cat. No.: HY-P99899
CAS No.: 2052591-32-7
Synonyms: PR-1498487

Target:  

ADC Antibodies

Research Areas:  

Cancer

Samrotamab (PR-1498487) is a humanized IgG1-κ chimeric monoclonal antibody targeting LRRC15, with a Kd of 5.42 nM for human LRRC15. Samrotamab disrupts the LRRC15-SCG5 signaling module by binding to a membrane-proximal conformational epitope within the C-terminal leucine-rich repeat region of LRRC15, which locates at the lateral edge of the LRR solenoid while fully exposing the canonical concave β-sheet surface. Samrotamab reduces the viability of bladder cancer cells, inhibits clonogenic growth, impairs cell migration and compromises cell invasion. Samrotamab induces compensatory upregulation of LRRC15 transcripts while suppressing the expression of SCG5 mRNA. Samrotamab is applicable to research on urothelial carcinoma, sarcoma, osteosarcoma and undifferentiated pleomorphic sarcoma .
loading...
    loading...
Cat. No.: HY-P99237
CAS No.: 1615692-28-8
Synonyms: MMUC 1206A

Target:  

Mucin

Research Areas:  

Others Cancer

Sofituzumab (MMUC 1206A) is an anti-MUC16 antibody with a Kd of 0.3-0.9 nM. Sofituzumab can bind multiple adjacent antibody molecules to the repeat sequences of the same MUC16 molecule. Sofituzumab exhibits no anti-tumor activity in the HPAC pancreatic adenocarcinoma xenograft model .
loading...
    loading...